Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy")

Toxicology Letters

Volumn 188, Issue 2, 2009, Pages 167-172

  Upreti, Vijay V ^a   Eddington, Natalie D ^a   Moon, Kwan Hoon ^b   Song, Byoung Joon ^b   Lee, Insong J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; Acetaldehyde; Aldehyde dehydrogenase; Drug interaction; Ethanol; Liver toxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETALDEHYDE; ALCOHOL; ALDEHYDE DEHYDROGENASE ISOENZYME 2; AMINOTRANSFERASE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; LIVER; LIVER CELL DAMAGE; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETALDEHYDE; ALDEHYDE DEHYDROGENASE; ANIMALS; DRUG INTERACTIONS; ETHANOL; HEPATITIS, TOXIC; ISOENZYMES; MALE; MITOCHONDRIA, LIVER; MITOCHONDRIAL PROTEINS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 65549105425     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.03.023     Document Type: Article

References (51)

1. Andreu V., Mas A., Bruguera M., Salmeron J.M., Moreno V., Nogue S., and Rodes J. Ecstasy: a common cause of severe acute hepatotoxicity. J. Hepatol. 29 (1998) 394-397
2. Barrett S.P., Darredeau C., and Pihl R.O. Patterns of simultaneous polysubstance use in drug using university students. Hum. Psychopharmacol. 21 (2006) 255-263
3. Beitia G., Cobreros A., Sainz L., and Cenarruzabeitia E. Ecstasy-induced toxicity in rat liver. Liver 20 (2000) 8-15
4. Ben-Abraham R., Szold O., Rudick V., and Weinbroum A.A. 'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting. Eur. J. Emerg. Med. 10 (2003) 309-313
5. Boyd C.J., McCabe S.E., and d'Arcy H. Ecstasy use among college undergraduates: gender, race and sexual identity. J. Subst. Abuse Treat. 24 (2003) 209-215
6. Brooks P.J. DNA damage, DNA repair, and alcohol toxicity-a review. Alcohol. Clin. Exp. Res. 21 (1997) 1073-1082
7. Deitrich R.A., Troxell P.A., and Worth W.S. Inhibition of aldehyde dehydrogenase in brain and liver by cyanamide. Biochem. Pharmacol. 25 (1976) 2733-2737
8. Ellis A.J., Wendon J.A., Portmann B., and Williams R. Acute liver damage and ecstasy ingestion. Gut 38 (1996) 454-458
9. Fidler H., Dhillon A., Gertner D., and Burroughs A. Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis. J. Hepatol. 25 (1996) 563-566
10. Gammella J.F., Alvarez-Roldon A., and Romo N. The content of ecstasy in Spain. In: Korf D.J., and H R. (Eds). Proceedings of the 17th Annual Conference on Drug Use and Drug Policy. Siswo, Amsterdam (1997) 130-138
11. Garbino J., Henry J.A., Mentha G., and Romand J.A. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option. Vet. Hum. Toxicol. 43 (2001) 99-102
12. Hartley D.P., Ruth J.A., and Petersen D.R. The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Arch. Biochem. Biophys. 316 (1995) 197-205
13. Hawkins R.D., and Kalant H. The metabolism of ethanol and its metabolic effects. Pharmacol. Rev. 24 (1972) 67-157
14. He Z.J., Ericksson P., Alho H., Harmoinen A., and Nordback I. Effects on endogenous acetaldehyde production by disulfiram and ethanol feeding on rat pancreas. J. Gastrointest. Surg. 5 (2001) 531-539
15. Hernandez-Lopez C., Farre M., Roset P.N., Menoyo E., Pizarro N., Ortuno J., Torrens M., Cami J., and de La Torre R. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J. Pharmacol. Exp. Ther. 300 (2002) 236-244
16. Isse T., Matsuno K., Oyama T., Kitagawa K., and Kawamoto T. Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity shows high acetaldehyde level in blood, brain, and liver after ethanol gavages. Alcohol. Clin. Exp. Res. 29 (2005) 1959-1964
17. Izco M., Orio L., O'Shea E., and Colado M.I. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Psychopharmacology (Berl.) 189 (2007) 459-470
18. Johansson B., Angelo H.R., Christensen J.K., Moller I.W., and Ronsted P. Dose-effect relationship of disulfiram in human volunteers. II. A study of the relation between the disulfiram-alcohol reaction and plasma concentrations of acetaldehyde, diethyldithiocarbamic acid methyl ester, and erythrocyte aldehyde dehydrogenase activity. Pharmacol. Toxicol. 68 (1991) 166-170
19. Johnsen J., Stowell A., and Morland J. Clinical responses in relation to blood acetaldehyde levels. Pharmacol. Toxicol. 70 (1992) 41-45
20. Kinoshita H., Jessop D.S., Roberts D.J., Ameno K., Ijiri I., Hishida S., and Harbuz M.S. Effects of acetaldehyde on c-fos mRNA induction in the paraventricular nucleus following ethanol administration. Alcohol Alcohol. 37 (2002) 432-435
21. Klyosov A.A. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes. Biochemistry 35 (1996) 4457-4467
22. Klyosov A.A., Rashkovetsky L.G., Tahir M.K., and Keung W.M. Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism. Biochemistry 35 (1996) 4445-4456
23. Kozutsumi D., Arita M., Kawashima A., Adachi M., and Takami M. An improved method for acetaldehyde determination in blood by high-performance liquid chromatography and solid-phase extraction. J. Chromatogr. Sci. 40 (2002) 477-482
24. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34 (2004) 9-19
25. Lieber C.S. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab. Rev. 36 (2004) 511-529
26. Livy D.J., Parnell S.E., and West J.R. Blood ethanol concentration profiles: a comparison between rats and mice. Alcohol 29 (2003) 165-171
27. Mitchell D.Y., and Petersen D.R. Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase-mediated acetaldehyde oxidation by trans-4-hydroxy-2-nonenal. Hepatology 13 (1991) 728-734
28. Moon K.H., Abdelmegeed M.A., and Song B.J. Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver. FEBS Lett. 581 (2007) 3967-3972
29. Moon K.H., Kim B.J., and Song B.J. Inhibition of mitochondrial aldehyde dehydrogenase by nitric oxide-mediated S-nitrosylation. FEBS Lett. 579 (2005) 6115-6120
30. Moon K.H., Upreti V.V., Yu L.R., Lee I.J., Ye X., Eddington N.D., Veenstra T.D., and Song B.J. Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 8 (2008) 3906-3918
31. Nakamura Y., Yokoyama H., Higuchi S., Hara S., Kato S., and Ishii H. Acetaldehyde accumulation suppresses Kupffer cell release of TNF-Alpha and modifies acute hepatic inflammation in rats. J. Gastroenterol. 39 (2004) 140-147
32. Niemelä O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic. Biol. Med. 31 (2001) 1533-1538
33. Pacifici R., Zuccaro P., Hernandez Lopez C., Pichini S., Di Carlo S., Farre M., Roset P.N., Ortuno J., Segura J., and Torre R.L. Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. J. Pharmacol. Exp. Ther. 296 (2001) 207-215
34. Pontes H., Duarte J.A., de Pinho P.G., Soares M.E., Fernandes E., Dinis-Oliveira R.J., Sousa C., Silva R., Carmo H., Casal S., Remiao F., Carvalho F., and Bastos M.L. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice. Toxicology 252 (2008) 64-71
35. Rashkovetsky L.G., Maret W., and Klyosov A.A. Human liver aldehyde dehydrogenases: new method of purification of the major mitochondrial and cytosolic enzymes and re-evaluation of their kinetic properties. Biochim. Biophys. Acta 1205 (1994) 301-307
36. Sauter A.M., Boss D., and von Wartburg J.P. Reevaluation of the disulfiram-alcohol reaction in man. J. Stud. Alcohol 38 (1977) 1680-1695
37. Strote J., Lee J.E., and Wechsler H. Increasing MDMA use among college students: results of a national survey. J. Adolesc. Health 30 (2002) 64-72
38. Svanas G.W., and Weiner H. Aldehyde dehydrogenase activity as the rate-limiting factor for acetaldehyde metabolism in rat liver. Arch. Biochem. Biophys. 236 (1985) 36-46
39. Tank A.W., Weiner H., and Thurman J.A. Enzymology and subcellular localization of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4-dihydroxyphenylacetic acid. Biochem. Pharmacol. 30 (1981) 3265-3275
40. Topp L., Hando J., Dillon P., Roche A., and Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 55 (1999) 105-115
41. Tsai C.S., and Senior D.J. Chemical studies of high-Km aldehyde dehydrogenase from rat liver mitochondria. Biochem. Cell Biol. 69 (1991) 193-197
42. Tuma D.J., Thiele G.M., Xu D., Klassen L.W., and Sorrell M.F. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 23 (1996) 872-880
43. Upreti V.V., and Eddington N.D. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat. J. Pharm. Sci. 97 (2008) 1593-1605
44. Winstock A.R., Griffiths P., and Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend. 64 (2001) 9-17
45. Wolff P.H. Ethnic differences in alcohol sensitivity. Science 175 (1972) 449-450
46. Yokoyama A., Kato H., Yokoyama T., Tsujinaka T., Muto M., Omori T., Haneda T., Kumagai Y., Igaki H., Yokoyama M., Watanabe H., Fukuda H., and Yoshimizu H. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis 23 (2002) 1851-1859
47. Yokoyama A., Muramatsu T., Ohmori T., Yokoyama T., Okuyama K., Takahashi H., Hasegawa Y., Higuchi S., Maruyama K., Shirakura K., and Ishii H. Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19 (1998) 1383-1387
48. Yokoyama A., Watanabe H., Fukuda H., Haneda T., Kato H., Yokoyama T., Muramatsu T., Igaki H., and Tachimori Y. Multiple cancers associated with esophageal and oropharyngolaryngeal squamous cell carcinoma and the aldehyde dehydrogenase-2 genotype in male Japanese drinkers. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 895-900
49. Yokoyama H., Ishii H., Nagata S., Moriya S., Ito T., Kato S., and Tsuchiya M. Heterogeneity of hepatic acetaldehyde adducts in guinea-pigs after chronic ethanol administration: an immunohistochemical analysis with monoclonal and polyclonal antibodies against acetaldehyde-modified protein epitopes. Alcohol Alcohol. 1A Suppl. (1993) 91-97
50. Yokoyama H., Nagata S., Moriya S., Kato S., Ito T., Kamegaya K., and Ishii H. Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts. Hepatology 21 (1995) 1438-1442
51. Yoshida A., Huang I.Y., and Ikawa M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in orientals. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 258-261